We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BIOAF market cap is 317.66k. The company's latest EPS is CAD -0.0373 and P/E is 0.00.
| Year End 28 February 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 589k | 1.42M | 606k | 4.08M | 37k |
| Operating Income | -5.28M | -4.86M | -4.6M | 271k | -3.6M |
| Net Income | -5.31M | -3.47M | -4.06M | 698k | -2.96M |
| Year End 28 February 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.22M | 1.74M | 941k | 3.28M | 2.27M |
| Total Liabilities | 787k | 2.29M | 3.43M | 2.87M | 4.18M |
| Total Equity | 434k | -546k | -2.49M | 407k | -1.92M |
| Year End 28 February 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.67M | -3.23M | -3.3M | 1.77M | -3.64M |
| Investing | -107k | 393k | N/A | 7k | N/A |
| Financing | 3.91M | 3.53M | 2.49M | 312k | 2.64M |
| Market Cap | 317.66k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 79.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 4k |
| 52 Week Change | -66.67% |
| 52 Week High | 0.012 |
| 52 Week Low | 0.0015 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bioasis Technologies Inc (CE) |
| Address |
200, 4170 still creek drive, burnaby burnaby, british columbia V5C 6C6 |
| Website | https://www.bioasis.us |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
